126 related articles for article (PubMed ID: 11444729)
1. Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer.
Moskalik AP; Rubin MA; Wojno KJ; Bree R; Rubin JM; Fowlkes JB; Montie JE; Manley S; Carson PL
J Ultrasound Med; 2001 Jul; 20(7):713-22. PubMed ID: 11444729
[TBL] [Abstract][Full Text] [Related]
2. Doppler quantitative measures by region to discriminate prostate cancer.
Potdevin TC; Moskalik AP; Fowlkes JB; Bude RO; Carson PL
Ultrasound Med Biol; 2001 Oct; 27(10):1305-10. PubMed ID: 11731043
[TBL] [Abstract][Full Text] [Related]
3. Analysis of three-dimensional ultrasound Doppler for the detection of prostate cancer.
Moskalik A; Carson PL; Rubin JM; Bree RL; Fowlkes JB; Rubin MA; Wojno K; Manley S; Montie JE
Urology; 2001 Jun; 57(6):1128-32. PubMed ID: 11377325
[TBL] [Abstract][Full Text] [Related]
4. Correlation between prostate cancer grade and vascularity on color doppler imaging: preliminary findings.
Tang J; Li S; Li J; Luo Y; Xu J; Zhang Y; Li X; Shi H; Zhang G
J Clin Ultrasound; 2003 Feb; 31(2):61-8. PubMed ID: 12539246
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer.
Strohmeyer D; Frauscher F; Klauser A; Recheis W; Eibl G; Horninger W; Steiner H; Volgger H; Bartsch G
Anticancer Res; 2001; 21(4B):2907-13. PubMed ID: 11712785
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasonography for the detection and characterization of prostate cancer: correlation with microvessel density and Gleason score.
Jiang J; Chen Y; Zhu Y; Yao X; Qi J
Clin Radiol; 2011 Aug; 66(8):732-7. PubMed ID: 21524418
[TBL] [Abstract][Full Text] [Related]
7. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer.
Sedelaar JP; van Leenders GJ; Hulsbergen-van de Kaa CA; van der Poel HG; van der Laak JA; Debruyne FM; Wijkstra H; de la Rosette JJ
Eur Urol; 2001 Sep; 40(3):285-93. PubMed ID: 11684844
[TBL] [Abstract][Full Text] [Related]
8. Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis.
Yang WT; Tse GM; Lam PK; Metreweli C; Chang J
J Ultrasound Med; 2002 Nov; 21(11):1227-35. PubMed ID: 12418764
[TBL] [Abstract][Full Text] [Related]
9. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
[TBL] [Abstract][Full Text] [Related]
10. Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer.
Strigari L; Marsella A; Canitano S; Gomellini S; Arcangeli S; Genovese E; Saracino B; Petrongari MG; Sentinelli S; Crecco M; Benassi M; Arcangeli G
Med Phys; 2008 Nov; 35(11):4793-9. PubMed ID: 19070211
[TBL] [Abstract][Full Text] [Related]
11. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival.
Ismail M; Petersen RO; Alexander AA; Newschaffer C; Gomella LG
Urology; 1997 Dec; 50(6):906-12. PubMed ID: 9426722
[TBL] [Abstract][Full Text] [Related]
12. Transrectal colour Doppler ultrasonography for quantifying angiogenesis in prostate cancer.
Shigeno K; Igawa M; Shiina H; Kishi H; Urakami S
BJU Int; 2003 Feb; 91(3):223-6. PubMed ID: 12581009
[TBL] [Abstract][Full Text] [Related]
13. Suspicious breast lesions: assessment of 3D Doppler US indexes for classification in a test population and fourfold cross-validation scheme.
LeCarpentier GL; Roubidoux MA; Fowlkes JB; Krücker JF; Hunt KA; Paramagul C; Johnson TD; Thorson NJ; Engle KD; Carson PL
Radiology; 2008 Nov; 249(2):463-70. PubMed ID: 18936310
[TBL] [Abstract][Full Text] [Related]
14. Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity.
Arger PH; Malkowicz SB; VanArsdalen KN; Sehgal CM; Holzer A; Schultz SM
J Ultrasound Med; 2004 May; 23(5):623-30. PubMed ID: 15154528
[TBL] [Abstract][Full Text] [Related]
15. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results.
Jung EM; Wiggermann P; Greis C; Eder F; Ehrich J; Jung W; Schreyer AG; Stroszczynski C; Ganzer R
Clin Hemorheol Microcirc; 2012; 52(2-4):167-77. PubMed ID: 22975940
[TBL] [Abstract][Full Text] [Related]
16. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
[TBL] [Abstract][Full Text] [Related]
17. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound.
Cho JY; Kim SH; Lee SE
Eur Urol; 2000 Apr; 37(4):443-8. PubMed ID: 10765075
[TBL] [Abstract][Full Text] [Related]
18. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings.
Cornud F; Hamida K; Flam T; Hélénon O; Chrétien Y; Thiounn N; Correas JM; Casanova JM; Moreau JF
AJR Am J Roentgenol; 2000 Oct; 175(4):1161-8. PubMed ID: 11000183
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection using power Doppler imaging.
Okihara K; Ukimura O; Mizutani Y; Kawauchi A; Nakao M; Miki T
Drugs Today (Barc); 2003 Jun; 39(6):389-98. PubMed ID: 12944993
[TBL] [Abstract][Full Text] [Related]
20. Prostate: high-frequency Doppler US imaging for cancer detection.
Halpern EJ; Frauscher F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
Radiology; 2002 Oct; 225(1):71-7. PubMed ID: 12354987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
